机器之心 (微信公众号)T2·Models
58 pts
Biotech startup Exin Therapeutics had GPT-6.1 Sol perform skull landmark targeting across three consecutive live mouse brain surgeries, with a professional surgeon correcting each round and the model retaining images and measurements for the next attempt. By round three, targeting time fell from 169s to 86s, corrections dropped from four to two, and error narrowed from 0.6mm to 0.3mm. With only three trials the result is far from proven surgical competence, but it illustrates an in-context learning loop that carries real-world feedback into subsequent tasks.